The Netherlands: Blomfield to chair Affidea’s new Supervisory Board as Recchi steps away from CEO role

Guy Blomfield, Affidea's interim CEO and chair of Supervisory Board

Following its July acquisition of a majority stake in Affidea, the largest European provider of advanced diagnostics, outpatient and cancer care services, GBL is initiating changes in the company’s governance, including the composition of a new Supervisory Board. Guy Blomfield, former CEO of Alliance Medical, has been appointed chairman of the Supervisory Board and will…

You must be a HMI Subscriber to view this content.

Subscribe Now »